Active ingredients: apalutamide
What it is used for
ERLYAND (apalutamide) is indicated for the treatment of patients with: metastatic castration-sensitive prostate cancer (mCSPC) or non-metastatic, castration-resistant prostate cancer (nmCRPC)
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 30 degrees Celsius
- Protect from Light
- Protect from Moisture
- Store in Original Container
- Shelf lifetime is 36 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Slightly yellowish green to greyish green, oblong-shaped, film-coated tablets, debossed with AR 60 on one side.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient apalutamide
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.